Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety

By sjmartinez • April 15, 2023

Honig S, Gittelman M, Kaminetsky J, Wang C, Amory JK, Rohowsky N, Dudley RE, Woun Seo B, Newmark J, Swerdloff R. Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety. J Sex Med. 2022 Dec 1;19(12):1750-1758. doi: 10.1016/j.jsxm.2022.09.002. PMID: 37057401.

Tags: Endocrinology, Male Hypogonadism, Oral Testosterone, Publications, testosterone, Testosterone Undecanoate

Active Surveillance and Conversion Surgery for Low-Risk Thyroid Cancer-The Disconnect Between Literature and Practice

Ho AS, Davies L, Yeh MW. Active Surveillance and Conversion Surgery for Low-Risk Thyroid Cancer-The Disconnect Between Literature and Practice. JAMA Otolaryngol Head Neck Surg.[...]

LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes

Ding J, Nguyen AT, Lohman K, Hensley MT, Parker D, Hou L, Taylor J, Voora D, Sawyer JK, Boudyguina E, Bancks MP, Bertoni A, Pankow[...]

30 years of (re)productive biology: a symposium honoring professor Martin M. Matzuk, MD, PhD

Kumar TR, Burns KH, Yan W. 30 years of (re)productive biology: a symposium honoring professor Martin M. Matzuk, MD, PhD. Biol Reprod. 2024 May 9;110(5):852-853.[...]